Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding study of oliceridine combined with propofol for day-surgery hysteroscopy
ChiCTR2500101669Phase 4Recruiting
- Sponsor
- Zhejiang Xiaoshan Hospital
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of oliceridine and propofol in postoperative pain (5 arms), sponsored by Zhejiang Xiaoshan Hospital. Primary endpoint: Response rate in each dose group. Started Apr 2025; status: recruiting.
02
Drugs
oliceridinepropofol
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500101669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500101669.